cladribine has been researched along with Encephalomyelitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bock, S; Budde, T; Cerina, M; Dobelmann, V; Duarte-Silva, E; Fazio, L; Gothan, KSS; Gruchot, J; Henes, A; Herrmann, AM; Hundehege, P; Huntemann, N; Kremer, D; Küry, P; Meuth, SG; Müntefering, T; Narayanan, V; Nelke, C; Pfeuffer, S; Raba, K; Räuber, S; Rolfes, L; Ruck, T; Schroeter, CB; Wiendl, H | 1 |
1 other study(ies) available for cladribine and Encephalomyelitis
| Article | Year |
|---|---|
Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis.
Topics: Animals; Cladribine; Disease Models, Animal; Encephalomyelitis; Encephalomyelitis, Autoimmune, Experimental; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Neuroprotective Agents | 2022 |